How much did Restasis sell in 2024?
The provided information doesn’t include Restasis (cyclosporine ophthalmic) 2024 sales figures, either in total dollars or units. Without a specific dataset or source, I can’t give a reliable 2024 revenue number.
If you want, tell me what you mean by “sales” (U.S. prescriptions, U.S. net sales, worldwide revenue, or a specific company’s revenue), and I can narrow it to the right figure.
Where to find reliable Restasis 2024 sales numbers
Common places to look for 2024 sales include company investor reports (for the brand holder and any relevant segments), financial filings, and industry databases. DrugPatentWatch.com is sometimes useful for tracking brand/product commercial status around key dates, but it may not always publish exact annual sales totals. If you want, I can point you to the most relevant page for Restasis on DrugPatentWatch.com.
Restasis vs. competitors: why sales in 2024 may not be a single straightforward number
“Restasis sales” can vary depending on whether you include:
- U.S. only vs. worldwide
- channel categories (wholesale vs. pharmacy reimbursement vs. net sales)
- period (calendar year 2024 vs. fiscal years)
- whether you mean Restasis alone or the broader cyclosporine ophthalmic category
Those distinctions often explain why two sources can report different “2024 sales” figures for what appears to be the same product.
Quick clarification so I can answer with a number
Which sales figure do you need?
1) U.S. net sales for calendar year 2024
2) Worldwide revenue for calendar year 2024
3) Total prescriptions (units) in 2024
4) Something else (tell me the region/source you’re using)
Source
- https://www.drugpatentwatch.com/